Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jan-23 5:14 PM View:  | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 5,925,290 | -- | -- | (100%) 5.93M to 0 | |
| 07-Apr-22 4:54 PM View: | Enliven Therapeutics, Inc. (ELVN) | 06-Apr-22 | Sale | 255,463 | $1.10 | $281,827.00 | (9%) 2.87M to 2.61M | |
| 07-Apr-22 4:54 PM View: | Enliven Therapeutics, Inc. (ELVN) | 05-Apr-22 | Sale | 439,088 | $1.07 | $469,429.00 | (13%) 3.31M to 2.87M | |
| 26-Jan-22 6:02 PM View: | Casper Sleep Inc. (CSPR) | 25-Jan-22 | Disposition (change in control) | 6,222,500 | $6.90 | $42,935,300.00 | (100%) 6.22M to 0 | |
| 25-Jan-22 8:41 PM View: | Enliven Therapeutics, Inc. (ELVN) | 25-Jan-22 | Sale | 102,952 | $1.47 | $151,803.00 | (3%) 3.41M to 3.31M | |
| 25-Jan-22 8:41 PM View: | Enliven Therapeutics, Inc. (ELVN) | 24-Jan-22 | Sale | 19,984 | $1.55 | $31,017.20 | (< 1%) 3.43M to 3.41M | |
| 25-Jan-22 8:41 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Jan-22 | Sale | 11,622 | $1.67 | $19,389.00 | (< 1%) 3.44M to 3.43M | |
| 20-Jan-22 5:20 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Jan-22 | Sale | 6,295 | $1.81 | $11,385.10 | (< 1%) 3.45M to 3.44M | |
| 20-Jan-22 5:20 PM View: | Enliven Therapeutics, Inc. (ELVN) | 19-Jan-22 | Sale | 13,412 | $1.82 | $24,413.90 | (< 1%) 3.46M to 3.45M | |
| 20-Jan-22 5:20 PM View: | Enliven Therapeutics, Inc. (ELVN) | 18-Jan-22 | Market Sale | 6,848 | $1.89 | $12,927.00 | (< 1%) 3.47M to 3.46M | (11%) |
| 14-Jan-22 5:04 PM View: | Enliven Therapeutics, Inc. (ELVN) | 14-Jan-22 | Market Sale | 9,707 | $1.91 | $18,583.10 | (< 1%) 3.48M to 3.47M | (9%) |
| 14-Jan-22 5:04 PM View: | Enliven Therapeutics, Inc. (ELVN) | 13-Jan-22 | Market Sale | 7,209 | $1.93 | $13,886.00 | (< 1%) 3.48M to 3.48M | (9%) |
| 14-Jan-22 5:04 PM View: | Enliven Therapeutics, Inc. (ELVN) | 12-Jan-22 | Market Sale | 4,634 | $2.02 | $9,357.44 | (< 1%) 3.49M to 3.48M | (4%) |
| 11-Jan-22 5:54 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Jan-22 | Market Sale | 2,409 | $2.04 | $4,919.42 | (< 1%) 3.49M to 3.49M | < 1% |
| 11-Jan-22 5:54 PM View: | Enliven Therapeutics, Inc. (ELVN) | 10-Jan-22 | Market Sale | 1,751 | $2.00 | $3,502.00 | (< 1%) 3.49M to 3.49M | (2%) |
| 11-Jan-22 5:54 PM View: | Enliven Therapeutics, Inc. (ELVN) | 07-Jan-22 | Market Sale | 14,600 | $2.08 | $30,318.40 | (< 1%) 3.51M to 3.49M | 2% |
| 06-Jan-22 5:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 06-Jan-22 | Market Sale | 10,257 | $2.16 | $22,205.40 | (< 1%) 3.52M to 3.51M | 1% |
| 06-Jan-22 5:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 05-Jan-22 | Market Sale | 8,200 | $2.25 | $18,439.30 | (< 1%) 3.53M to 3.52M | 5% |
| 06-Jan-22 5:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 04-Jan-22 | Market Sale | 13,459 | $2.34 | $31,543.90 | (< 1%) 3.54M to 3.53M | 9% |
| 03-Jan-22 8:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 03-Jan-22 | Market Sale | 44,665 | $2.34 | $104,396.00 | (1%) 3.58M to 3.54M | 3% |
| 03-Jan-22 8:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 31-Dec-21 | Market Sale | 49,953 | $2.25 | $112,409.00 | (1%) 3.63M to 3.58M | (< 1%) |
| 03-Jan-22 8:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 30-Dec-21 | Market Sale | 21,858 | $2.29 | $50,065.70 | (< 1%) 3.66M to 3.63M | < 1% |
| 29-Dec-21 6:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Dec-21 | Market Sale | 15,196 | $2.30 | $34,953.80 | (< 1%) 3.67M to 3.66M | (2%) |
| 29-Dec-21 6:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 28-Dec-21 | Market Sale | 24,580 | $2.34 | $57,539.30 | (< 1%) 3.7M to 3.67M | (< 1%) |
| 29-Dec-21 6:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 27-Dec-21 | Market Sale | 27,651 | $2.42 | $67,006.70 | (< 1%) 3.72M to 3.7M | 3% |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Dec-21 | Market Sale | 23,961 | $2.41 | $57,746.00 | (< 1%) 3.75M to 3.72M | (3%) |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Dec-21 | Market Sale | 20,109 | $2.32 | $46,679.00 | (< 1%) 3.77M to 3.75M | (7%) |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Dec-21 | Market Sale | 41,222 | $2.32 | $95,804.10 | (1%) 3.81M to 3.77M | (7%) |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Dec-21 | Market Sale | 85,123 | $2.26 | $192,604.00 | (2%) 3.89M to 3.81M | (10%) |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Dec-21 | Market Sale | 44,993 | $2.23 | $100,546.00 | (1%) 3.94M to 3.89M | (11%) |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 15-Dec-21 | Market Sale | 28,817 | $2.28 | $65,685.50 | (< 1%) 3.97M to 3.94M | (9%) |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 14-Dec-21 | Market Sale | 15,093 | $2.56 | $38,642.60 | (< 1%) 3.98M to 3.97M | 3% |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 13-Dec-21 | Market Sale | 17,501 | $2.83 | $49,557.60 | (< 1%) 4.0M to 3.98M | 12% |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 10-Dec-21 | Market Sale | 8,667 | $2.83 | $24,541.50 | (< 1%) 4.01M to 4.0M | 12% |
| 27-Dec-21 4:34 PM View: | Enliven Therapeutics, Inc. (ELVN) | 09-Dec-21 | Market Sale | 5,666 | $2.95 | $16,693.20 | (< 1%) 4.01M to 4.01M | 15% |
| 16-Sep-20 4:41 PM View: | Mersana Therapeutics, Inc. (MRSN) | 14-Sep-20 | Disposition (other) | 2,000,000 | -- | -- | (25%) 7.96M to 5.96M | |
| 22-May-20 4:56 PM View: | Surface Oncology, Inc. (SURF) | 20-May-20 | Market Sale | 420,000 | $3.66 | $1,535,560.00 | (13%) 3.31M to 2.89M | (163%) |
| 13-Apr-20 9:08 PM View: | Mersana Therapeutics, Inc. (MRSN) | 09-Apr-20 | Disposition (other) | 4,000,000 | -- | -- | (33%) 11.96M to 7.96M | |
| 16-Mar-20 5:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Conversion | 3,539,000 | -- | -- | 100% 0 to 3.54M | |
| 16-Mar-20 5:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Purchase | 475,000 | $16.00 | $7,600,000.00 | 13% 3.54M to 4.01M | |
| 10-Mar-20 4:45 PM View: | Champions Biotechnology, Inc. (CSBR) | 06-Mar-20 | Market Sale | 708,155 | $6.99 | $4,950,000.00 | (29%) 2.42M to 1.71M | (58%) |
| 10-Mar-20 4:45 PM View: | Champions Biotechnology, Inc. (CSBR) | 06-Mar-20 | Exercise (in-the money or at-the-money) | 859,375 | $5.76 | $4,950,000.00 | 55% 1.56M to 2.42M | |
| 12-Feb-20 4:35 PM View: | Casper Sleep Inc. (CSPR) | 10-Feb-20 | Purchase | 1,250,000 | $12.00 | $15,000,000.00 | 25% 4.97M to 6.22M | |
| 12-Nov-19 5:00 PM View: | Galera Therapeutics, Inc. (GRTX) | 12-Nov-19 | Conversion | 3,941,380 | -- | -- | 100% 0 to 3.94M | |
| 12-Nov-19 5:00 PM View: | Galera Therapeutics, Inc. (GRTX) | 12-Nov-19 | Purchase | 416,666 | $12.00 | $4,999,990.00 | 11% 3.94M to 4.36M | |
| 04-Nov-19 6:04 PM View: | Oyster Point Pharma, Inc. (OYST) | 04-Nov-19 | Conversion | 4,667,830 | -- | -- | 1448% 322.46K to 4.99M | |
| 04-Nov-19 6:04 PM View: | Oyster Point Pharma, Inc. (OYST) | 04-Nov-19 | Purchase | 935,000 | $16.00 | $14,960,000.00 | 19% 4.99M to 5.93M | |
| 13-Apr-20 8:39 PM View: | Mersana Therapeutics, Inc. (MRSN) | 28-Aug-19 | Private Sale | 1,211 | $2.91 | $3,524.01 | (< 1%) 11.96M to 11.96M | |
| 13-Apr-20 8:39 PM View: | Mersana Therapeutics, Inc. (MRSN) | 28-Aug-19 | Exercise (in-the money or at-the-money) | 70,593 | $0.05 | $3,529.65 | < 1% 11.89M to 11.96M | |
| 06-Mar-19 4:38 PM View: | Mersana Therapeutics, Inc. (MRSN) | 05-Mar-19 | Private Purchase | 3,750,000 | $4.00 | $15,000,000.00 | 46% 8.14M to 11.89M |